FOLD logo

FOLDAmicus Therapeutics Inc

$14.49
$0.03
(0.21%)
Today
Closed $14.49
$0.00
(0.00%)
After Hours
Updated: 04:48 PM EDT
Reported EarningsFeb 20
Mkt Cap$4.55B
Vol5.29M
News
all
press releases
Pictet Asset Management Holding SA Trims Stake in Amicus Therapeutics, Inc. $FOLD
Pictet Asset Management Holding SA lessened its stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 70.6% during the fourth quarter, according to the company in its most...
MarketBeat
News Placeholder
More News
News Placeholder
Universal Beteiligungs und Servicegesellschaft mbH Decreases Holdings in Amicus Therapeutics, Inc. $FOLD
Universal Beteiligungs und Servicegesellschaft mbH cut its stake in shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 28.5% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 231,337 shares of the bi...
MarketBeat
News Placeholder
Best Biotech Stocks To Add to Your Watchlist - April 28th
Danaher, Medpace, Vertex Pharmaceuticals, Oruka Therapeutics, Amicus Therapeutics, argenex, and Moderna are the seven Biotech stocks to watch today, according to MarketBeat's stock screener tool...
MarketBeat
News Placeholder
CIBRA Capital Makes a Big Merger Arbitrage Bet On Amicus Therapeutics (FOLD)
Key PointsIncreased Amicus Therapeutics stake by 1,476,861 shares; estimated trade size $21.17 million (based on average price from January to March 2026...
Nasdaq News: Markets
News Placeholder
Amicus Therapeutics (NASDAQ:FOLD) Sets New 12-Month High - Time to Buy?
Amicus Therapeutics (NASDAQ:FOLD) Sets New 1-Year High - Should You Buy...
MarketBeat
News Placeholder
Massachusetts Financial Services Co. MA Has $1.79 Million Position in Amicus Therapeutics, Inc. $FOLD
Massachusetts Financial Services Co. MA reduced its stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) by 96.6% during the 4th quarter, according to the company in its most recent...
MarketBeat
News Placeholder
Amicus Therapeutics (NASDAQ:FOLD) Share Price Crosses Above 200 Day Moving Average - Here's What Happened
Amicus Therapeutics (NASDAQ:FOLD) Shares Pass Above 200 Day Moving Average - What's Next...
MarketBeat
News Placeholder
Amicus Therapeutics, Inc. (NASDAQ:FOLD) Given Consensus Rating of "Hold" by Brokerages
Shares of Amicus Therapeutics, Inc. (NASDAQ:FOLD - Get Free Report) have received an average recommendation of "Hold" from the thirteen analysts that are currently covering the stock, MarketBeat...
MarketBeat
News Placeholder
Amicus Therapeutics (NASDAQ:FOLD) Hits New 1-Year High - Time to Buy?
Amicus Therapeutics (NASDAQ:FOLD) Hits New 1-Year High - Still a Buy...
MarketBeat
News Placeholder
Capricorn Fund Managers Ltd Invests $3 Million in Amicus Therapeutics, Inc. $FOLD
Capricorn Fund Managers Ltd bought a new stake in Amicus Therapeutics, Inc. (NASDAQ:FOLD - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the...
MarketBeat
<
1
2
...
>